Paper39368987
Prodrug activation by 4,4'-bipyridine-mediated aromatic nitro reduction.
Wang Q and 5 others. Nat Commun, 2024. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Prodrug activation by 4,4'-bipyridine-mediated aromatic nitro reduction. Papers, record 39368987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39368987
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prodrugs | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Indoles | |
| Oxidation-Reduction | |
| Pyridines | |
| Catalysis | |
| Nitro Compounds | |
| Cell Line, Tumor |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Dushi plan | Tsinghua University (THU) | PubMed |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14678739 | The growing impact of click chemistry on drug discovery. | Drug Discov Today | 2003 | https://conductscience.org/library/papers/14678739 | PubMed |
| 2 | 19714693 | Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. | Angew Chem Int Ed Engl | 2009 | https://conductscience.org/library/papers/19714693 | PubMed |
| 3 | 20177591 | Bioorthogonal chemistry: recent progress and future directions. | Chem Commun (Camb) | 2010 | https://conductscience.org/library/papers/20177591 | PubMed |
| 4 | 25237856 | Click chemistry in complex mixtures: bioorthogonal bioconjugation. | Chem Biol | 2014 | https://conductscience.org/library/papers/25237856 | PubMed |
| 5 | 24437719 | Finding the right (bioorthogonal) chemistry. | ACS Chem Biol | 2014 | https://conductscience.org/library/papers/24437719 | PubMed |
| 6 | 30159392 | The Future of Bioorthogonal Chemistry. | ACS Cent Sci | 2018 | https://conductscience.org/library/papers/30159392 | PubMed |
| 7 | 34163888 | Click activated protodrugs against cancer increase the therapeutic potential of chemotherapy through local capture and activation. | Chem Sci | 2021 | https://conductscience.org/library/papers/34163888 | PubMed |
| 8 | 37521794 | Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents. | ACS Cent Sci | 2023 | https://conductscience.org/library/papers/37521794 | PubMed |
| 9 | 26881764 | Development and application of bond cleavage reactions in bioorthogonal chemistry. | Nat Chem Biol | 2016 | https://conductscience.org/library/papers/26881764 | PubMed |
| 10 | 30724944 | Click and release: bioorthogonal approaches to "on-demand" activation of prodrugs. | Chem Soc Rev | 2019 | https://conductscience.org/library/papers/30724944 | PubMed |
| 11 | 34235254 | Unleashing the Power of Bond Cleavage Chemistry in Living Systems. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34235254 | PubMed |
| 12 | 24651204 | Palladium-triggered deprotection chemistry for protein activation in living cells. | Nat Chem | 2014 | https://conductscience.org/library/papers/24651204 | PubMed |
| 13 | 24522696 | Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach. | Nat Commun | 2014 | https://conductscience.org/library/papers/24522696 | PubMed |
| 14 | 28699627 | Nano-palladium is a cellular catalyst for in vivo chemistry. | Nat Commun | 2017 | https://conductscience.org/library/papers/28699627 | PubMed |
| 15 | 28699691 | Gold-Triggered Uncaging Chemistry in Living Systems. | Angew Chem Int Ed Engl | 2017 | https://conductscience.org/library/papers/28699691 | PubMed |
| 16 | 30288239 | Tetrazine-mediated bioorthogonal prodrug-prodrug activation. | Chem Sci | 2018 | https://conductscience.org/library/papers/30288239 | PubMed |
| 17 | 29927585 | Bioorthogonal Removal of 3-Isocyanopropyl Groups Enables the Controlled Release of Fluorophores and Drugs in Vivo. | J Am Chem Soc | 2018 | https://conductscience.org/library/papers/29927585 | PubMed |
| 18 | 30487642 | Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems. | Nat Commun | 2018 | https://conductscience.org/library/papers/30487642 | PubMed |
| 19 | 31620674 | Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis. | Nat Catal | 2019 | https://conductscience.org/library/papers/31620674 | PubMed |
| 20 | 32162393 | Intracellular Reactions Promoted by Bis(histidine) Miniproteins Stapled Using Palladium(II) Complexes. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/32162393 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42554310 | Nitro Reduction-Based RNA Control and Ultrafast Release. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42554310 | PubMed |
| 42422280 | Photoinduced reduction of nitro(hetero)arenes with earth-abundant FeCl3 promoter. | RSC Adv | 2026 | https://conductscience.org/library/papers/42422280 | PubMed |
| 42136135 | Metal-Free, Chemoselective Reduction of Aromatic Nitro Compounds in Water at Room Temperature. | ChemistryOpen | 2026 | https://conductscience.org/library/papers/42136135 | PubMed |
| 41803325 | Unlocking the black box: multimodal imaging and quantitative analysis of plant vesicular trafficking. | Adv Biotechnol (Singap) | 2026 | https://conductscience.org/library/papers/41803325 | PubMed |
| 41776230 | Accelerated synthesis of immunomodulatory imide drugs and their derivatives via continuous flow chemistry. | Commun Chem | 2026 | https://conductscience.org/library/papers/41776230 | PubMed |
| 41768769 | Directed Evolution of Enzymes for Bioorthogonal Chemistry Using Acid Chloride Proximity Labeling. | ACS Cent Sci | 2026 | https://conductscience.org/library/papers/41768769 | PubMed |
| 41545418 | Spatiotemporally controlled drug release via a click-release system utilizing mono-alkyl-hydroxylamine and cyclooctyne chemistry. | Nat Commun | 2026 | https://conductscience.org/library/papers/41545418 | PubMed |
| 40927638 | Targeting Tumor-Associated Hypoxia with Bioreductively Activatable Prodrug Conjugates Derived from Dihydronaphthalene, Benzosuberene, and Indole-based Inhibitors of Tubulin Polymerization. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40927638 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39368987
GET https://conductscience.org/api/papers/v1/39368987/references?page=2